Skip to content

NovoCure NVCR Amortization Of Debt Discount Premium

Amortization Of Debt Discount Premium at other companies

NXP Semiconductors logo
NXP SemiconductorsNXPI
$1M0.0%
Microchip Technology logo
Microchip TechnologyMCHP
$7.6M-42.4%
Lumentum Holdings Inc. logo
Lumentum Holdings Inc.LITE
$1.1M+37.5%
ON Semiconductor logo
ON SemiconductorON
$2.9M0.0%
Devon Energy logo
Devon EnergyDVN
$4M-33.3%
Extra Space Storage logo
Extra Space StorageEXR
$12.56M+11.0%

Other financials

Income statement

See full
Revenue$174.1M+12.3%
Gross profit$135.1M+16.0%
Operating income-$67.4M-78.1%
Net income-$71.1M-107%
EPS (diluted)-$0.62-100%

Balance sheet

See full
Cash & equivalents$87.5M-31.2%
Total debt$39.5M-2.1%
Total equity$330.7M-8.6%
Total assets$787.9M-36.9%

Cash flow

See full
Operating cash flow-$13.5M+62.1%
CapEx$5.2M-51.4%
Free cash flow-$18.7M+59.7%

Valuation

See full
Market cap$1.7B-36.7%
Enterprise value$1.66B-36.3%
P/S2.5×-1.8×

Profitability

See full
Gross margin75.2%-2.0pp
Operating margin-27.2%+0.4pp
Net margin-25.7%-0.7pp
FCF margin-7.1%-2.0pp

Returns & leverage

See full
Return on equity-50%+5.4pp
Debt / equity0.1×0.0×
Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfDebtDiscountPremium.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's amortization of debt discount premium.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NovoCure's amortization of debt discount premium?
NovoCure (NVCR) reported amortization of debt discount premium of -$2.62M in Q1 2026.
How has NovoCure's amortization of debt discount premium changed year-over-year?
NovoCure's amortization of debt discount premium increased by 60.7% year-over-year, from -$6.65M to -$2.62M.
What is the long-term trend for NovoCure's amortization of debt discount premium?
Over 4 years (2021 to 2025), NovoCure's amortization of debt discount premium has grown at a 65.5% compound annual growth rate (CAGR), from $3.1M to -$23.26M.